Skip to contentS
Syra Health Corp
S
SYRASyra Health Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.73M$1.73Mderived−13.6% vs Q4 2024 Net Income-$134.57K-$134.57KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$591,170+76.5% Operating Incomederived-$135,661N/M Operating Cash Flowderived-$289,192N/M Margins · derivedGross margin34.1%+17.4 pt vs Q4 2024
Operating margin-7.8%+17.2 pt vs Q4 2024
Net margin-7.8%+17.4 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 12, 2026 · 71 d after period end